# NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
> **ANDA207597** · Abbreviated New Drug Application (Generic) · Sponsor: P AND L · Approved 2019-01-25
## Drug
- **FDA Application Number:** ANDA207597
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
- **Generic name:** Diphenhydramine Hydrochloride
- **Active ingredients:** DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** P AND L
- **First approval:** 2019-01-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207597)
---
*MORVS · CC0 1.0*